Genotype-specific MRD interpretation improves stratification in paediatric acute lymphoblastic leukaemia

Míreanna comhchosúla

• Cytogenetic-specific heterogeneity in the kinetics of minimal residual disease (MRD) clearance in childhood acute lymphoblastic leukaemia (ALL)
  de réir: Moorman, A, et al.
  Foilsithe / Cruthaithe: (2007)
• Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia.
  de réir: O'Connor, D, et al.
  Foilsithe / Cruthaithe: (2017)
• A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia.
  de réir: Moorman, A, et al.
  Foilsithe / Cruthaithe: (2014)
• Post-Remission MRD Kinetics in Children with Acute Lymphoblastic Leukaemia Receiving Augmented BFM Consolidation Compared with Other Regimens Results of the Medical Research Council Trial UKALL2003.
  de réir: Cutting, R, et al.
  Foilsithe / Cruthaithe: (2008)
• Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol.
  de réir: Patrick, K, et al.
  Foilsithe / Cruthaithe: (2014)